Naproxen/esomeprazole (Vimovo).
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D064098:Esomeprazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control; D041981:Gastrointestinal Tract / Q000187:drug effects; D006801:Humans; D009288:Naproxen / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D054328:Proton Pump Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D054328:Proton Pump Inhibitors; D009288:Naproxen; D064098:Esomeprazole